FAS and non-Hodgkin lymphoma: Previous reports of no association with NHL risk with variants in BCL2[31], [54], [55], BCL6[56], [57], BCL10[31], [58], BAX[31], [54], FAS[59], and MDM2[60], [61], [62] are consistent with our negative findings.